Symposium D - Immunization Information Management and Innovation in the Digital Era: Insights and Prospects from China and Australia
Tracks
Track 6
| Wednesday, June 11, 2025 |
| 3:30 PM - 4:55 PM |
| Riverbank Room 4 |
Overview
Organisation: Chinese Preventive Medicine Association
Details
Hosted by: Chinese Preventive Medicine Association and Australia National Centre for Immunisation Research and Surveillance
Facilitated by: Prof. Kristine Macartey, Director, Australia National Centre for Immunisation Research and Surveillance
Symposium Summary:
This symposium will focus on advancing immunization informatization and sharing practical experiences and innovative achievements from China and Australia. It will also address challenges faced by both countries and the global community. Key topics include developing immunization information management systems, managing immunization data (including collection, sharing, storage, analysis, etc.), and applying innovative technologies to improve immunization coverage and operational efficiency. Through fostering the exchange of experiences and knowledge, the symposium seeks to strengthen collaboration and mutual learning among Chinese, Australian, and international stakeholders. Ultimately, the event aims to promote the sustainable development of immunization informatization, contributing to enhanced national, regional and global public health outcomes. By serving as a platform for cooperation, the symposium will uncover best practices and drive the development of innovative solutions, such as AI-driven data analytics and digital health tools.
Speakers:
1. Prof. Bin Li, President, Chinese Preventive Medicine Association
2. Dr. Zundong Yin, Director of National Immunization Program, Chinese Center for Disease Control and Prevention
3. Prof. Kristine Macartey, Director, Australia National Centre for Immunisation Research and Surveillance
4. Panel members -
a) Prof. Mark Jit, Professor and Chair of the Department, Global and Environmental Health at New York University
b) Prof. Kristine Macartney, Director of Australia National Centre for Immunisation Research and Survelliance
c) Prof. Zijian Feng, Professor of Southern University of Science and Technology; Vice President, Chinese Preventive Medicine Association
d) Dr. Zundong Yin, Director of National Immunization Program, Chinese Center for Disease Control and Prevention
e) Prof. Shenglan Tang, Co-Director and Professor of Global Health of the Global Health Research Center, Duke Kunshan University, China
For more details and to register go to: https://www.cdic2025.com/symposiums
There is no additional cost for attending symposiums but you will need to register as space is limited.
Speaker
Prof Bin Li
President
Chinese Preventive Medicine Association
Opening Remarks
Abstract
Briefly introduce the goals and vision of this syposium, call on Chinese, Australian, and international colleagues to learn from each other's experiences, promote information sharing, strengthen international cooperation, and jointly enhance global immunization information management level.
Dr Zundong Yin
Director Of National Immunization Program
Chinese Center For Disease Control And Prevention
Practice and prospect of immunization program information system in China
Abstract
Introduction: China's Immunization Information System (CIIS) has been progressively improved to take advantage of advances in information technology to meet an increasing demand for refined management of vaccination services, and established a comprehensive electronic traceability system for vaccines. The scope of this reconstruction project includes the National IIS and provincial-level integrated health information platform immunization information systems. The system integrates data from vaccination service points, including vaccination clinics, hospitals, and community health centers, and provides comprehensive information on vaccine inventory, vaccination activities, and adverse events following immunization (AEFI) monitoring reports.
Methods: By exchanging vaccination data with vaccine-preventable disease surveillance data, real-world vaccine effectiveness evaluations can be conducted. Through informatization methods, a combination of various approaches such as precise vaccination appointment scheduling, vaccination reminders, electronic health inquiries, electronic informed consent, electronic signatures, and QR code scanning for vaccination can be achieved.
Results: Although the construction of China's immunization information system has achieved remarkable results, in the face of emerging and sudden infectious disease challenges, it is still necessary to continuously strengthen the construction and application in areas such as system function improvement and expansion, data interoperability, data quality enhancement, management standardization, service diversification, and technological innovation.
Methods: By exchanging vaccination data with vaccine-preventable disease surveillance data, real-world vaccine effectiveness evaluations can be conducted. Through informatization methods, a combination of various approaches such as precise vaccination appointment scheduling, vaccination reminders, electronic health inquiries, electronic informed consent, electronic signatures, and QR code scanning for vaccination can be achieved.
Results: Although the construction of China's immunization information system has achieved remarkable results, in the face of emerging and sudden infectious disease challenges, it is still necessary to continuously strengthen the construction and application in areas such as system function improvement and expansion, data interoperability, data quality enhancement, management standardization, service diversification, and technological innovation.
Professor Kristine Macartney
Director
Australian National Centre for Immunisation Research and Surveillance (NCIRS)
Progress, functionality and application of Australia's Immunisation Register
Abstract
Introduction: The Australian Immunisation Register (AIR), established in 1996 to capture childhood vaccinations, was one of the first complete purpose-built national electronic childhood immunisation registers in the world. Since then, the AIR has expanded to include all ages and been updated with new functionalities to respond to immunisation program evolution.
Methods and results: The AIR is a key source for monitoring and evaluation of immunisation programs and informing program planning and delivery and for promoting equity; key examples of how it has been used will be presented. However, opportunities to better leverage to utility of the AIR to provide greater insights to strengthen evidence-based policy and practice. For example, use of the AIR for vaccine product tracking, linked AEFI reporting, or direct messaging (eg. pre-call/reminders for immunisation) to consumers using digital means will be explored. A user-friendly, tailored to context, digital dashboard reporting all vaccine coverage data to all immunisation stakeholders is also long-awaited. Better understanding of vaccine impact in key populations, such those as residential aged care, with disability, who are culturally diverse, pregnant or have underlying medical risk conditions is needed and can be garnered through a comprehensive and well supported strategic approach to leveraging AIR linkages with key evolving data assests, such as the Person Level Integrated Data Asset (PLIDA), managed by the Australian Bureau of Statistics, the Australian Institute of Health and Welfare (AIHW) National Health Data Hub, and state/territory linked data assets.
Methods and results: The AIR is a key source for monitoring and evaluation of immunisation programs and informing program planning and delivery and for promoting equity; key examples of how it has been used will be presented. However, opportunities to better leverage to utility of the AIR to provide greater insights to strengthen evidence-based policy and practice. For example, use of the AIR for vaccine product tracking, linked AEFI reporting, or direct messaging (eg. pre-call/reminders for immunisation) to consumers using digital means will be explored. A user-friendly, tailored to context, digital dashboard reporting all vaccine coverage data to all immunisation stakeholders is also long-awaited. Better understanding of vaccine impact in key populations, such those as residential aged care, with disability, who are culturally diverse, pregnant or have underlying medical risk conditions is needed and can be garnered through a comprehensive and well supported strategic approach to leveraging AIR linkages with key evolving data assests, such as the Person Level Integrated Data Asset (PLIDA), managed by the Australian Bureau of Statistics, the Australian Institute of Health and Welfare (AIHW) National Health Data Hub, and state/territory linked data assets.
Dr Melinda Chen
Senior Research Officer
NCIRS
Panel Discussion - How to leverage big data and digital technologies to improve vaccine access, coverage and inform policy?
Abstract
Introduction: Achieving high and equitable vaccine coverage is a core objective of global immunization programs, but they face numerous challenges. Key insights are also needed to inform and prioritise new vaccine introductions and optimise immunisation program delivery and impacts. Big data and digital technologies offer new opportunities in this regard.
Methods: The panel will discuss approaches to optimizing vaccine coverage and insights through big data analysis, streamline vaccination processes using digital tools, and model and evaluate program impact. Discussion will focus on relevance for all countries and settings. Interactive audience participation, citing other country examples, stakeholders key needs and experience sharing will be incorporated across the symposium.
Results: Big data and digital technologies hold great promise to improve global vaccine coverage and accessibility, benefiting low- and middle-income, as well as high-income countries. The symposium attendees will participate in a thought provoking and engaging dialogue to explore how such innovate is and can better be used to in vaccine preventable disease control.
Moderator: Dr. Melinda Chen, Senior Research Officer, Australia National Centre for Immunisation Research and Survelliance
Panelists:
- Prof. Mark Jit (TBC), Professor and Chair of the Department, Global and Environmental Health at New York University
- Prof. Kristine Macartney, Director of Australia National Centre for Immunisation Research and Survelliance
- Prof. Zijian Feng, Professor of Southern University of Science and Technology; Vice President, Chinese Preventive Medicine Association
- Dr. Zundong Yin, Director of National Immunization Program, Chinese Center for Disease Control and Prevention
- Prof. Shenglan Tang, Co-Director and Professor of Global Health of the Global Health Research Center, Duke Kunshan University, China
Methods: The panel will discuss approaches to optimizing vaccine coverage and insights through big data analysis, streamline vaccination processes using digital tools, and model and evaluate program impact. Discussion will focus on relevance for all countries and settings. Interactive audience participation, citing other country examples, stakeholders key needs and experience sharing will be incorporated across the symposium.
Results: Big data and digital technologies hold great promise to improve global vaccine coverage and accessibility, benefiting low- and middle-income, as well as high-income countries. The symposium attendees will participate in a thought provoking and engaging dialogue to explore how such innovate is and can better be used to in vaccine preventable disease control.
Moderator: Dr. Melinda Chen, Senior Research Officer, Australia National Centre for Immunisation Research and Survelliance
Panelists:
- Prof. Mark Jit (TBC), Professor and Chair of the Department, Global and Environmental Health at New York University
- Prof. Kristine Macartney, Director of Australia National Centre for Immunisation Research and Survelliance
- Prof. Zijian Feng, Professor of Southern University of Science and Technology; Vice President, Chinese Preventive Medicine Association
- Dr. Zundong Yin, Director of National Immunization Program, Chinese Center for Disease Control and Prevention
- Prof. Shenglan Tang, Co-Director and Professor of Global Health of the Global Health Research Center, Duke Kunshan University, China
